Jonathan D Davis1, Margaret A Olsen2, Kerry Bommarito3, Shane J LaRue4, Mohammed Saeed3, Michael W Rich4, Justin M Vader4. 1. Knight Cardiovascular Institute, Oregon Health & Science University, Portland. Electronic address: davjon@ohsu.edu. 2. Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Mo; Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, Mo. 3. Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Mo. 4. Division of Cardiology, Washington University School of Medicine, Saint Louis, Mo.
Abstract
BACKGROUND: Thirty-day readmission following heart failure hospitalization impacts hospital performance measures and reimbursement. We investigated readmission characteristics and the magnitude of 30-day hospital readmissions after hospital discharge for heart failure using the Healthcare Cost and Utilization Project State Inpatient Databases (SID). METHODS: Adults aged ≥ 40 years hospitalized with a primary discharge diagnosis of heart failure from 2007-2011 were identified in the California, New York, and Florida SIDs. Characteristics of patients with and without 7-, 8 to 30-, and 30-day readmission, and primary readmission diagnoses and risk factors for readmission were examined. RESULTS: We identified 547,068 patients with mean age 74.7 years; 50.7% were female, and 65.4% were White. Of 117,123 patients (21.4%) readmitted within 30 days (median 12 days), 69.7% had a non-heart failure primary readmission diagnosis. Patients with 30-day readmissions more frequently had a history of previous admission with heart failure as a secondary diagnosis, fluid and electrolyte disorders, and chronic deficiency anemia. There were no significant clinical differences at baseline between those patients whose first readmission was in the first 7 days after discharge vs in the next 23 days. The most common primary diagnoses for 30-day non-heart failure readmissions were other cardiovascular conditions (14.9%), pulmonary disease (8.5%), and infections (7.7%). CONCLUSIONS: In this large all-payer cohort, ∼70% of 30-day readmissions were for non-heart failure causes, and the median time to readmission was 12 days. Future interventions to reduce readmissions should focus on common comorbid conditions that contribute to readmission burden.
BACKGROUND: Thirty-day readmission following heart failure hospitalization impacts hospital performance measures and reimbursement. We investigated readmission characteristics and the magnitude of 30-day hospital readmissions after hospital discharge for heart failure using the Healthcare Cost and Utilization Project State Inpatient Databases (SID). METHODS: Adults aged ≥ 40 years hospitalized with a primary discharge diagnosis of heart failure from 2007-2011 were identified in the California, New York, and Florida SIDs. Characteristics of patients with and without 7-, 8 to 30-, and 30-day readmission, and primary readmission diagnoses and risk factors for readmission were examined. RESULTS: We identified 547,068 patients with mean age 74.7 years; 50.7% were female, and 65.4% were White. Of 117,123 patients (21.4%) readmitted within 30 days (median 12 days), 69.7% had a non-heart failure primary readmission diagnosis. Patients with 30-day readmissions more frequently had a history of previous admission with heart failure as a secondary diagnosis, fluid and electrolyte disorders, and chronic deficiency anemia. There were no significant clinical differences at baseline between those patients whose first readmission was in the first 7 days after discharge vs in the next 23 days. The most common primary diagnoses for 30-day non-heart failure readmissions were other cardiovascular conditions (14.9%), pulmonary disease (8.5%), and infections (7.7%). CONCLUSIONS: In this large all-payer cohort, ∼70% of 30-day readmissions were for non-heart failure causes, and the median time to readmission was 12 days. Future interventions to reduce readmissions should focus on common comorbid conditions that contribute to readmission burden.
Authors: Bradley G Hammill; Lesley H Curtis; Gregg C Fonarow; Paul A Heidenreich; Clyde W Yancy; Eric D Peterson; Adrian F Hernandez Journal: Circ Cardiovasc Qual Outcomes Date: 2010-12-07
Authors: William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav Journal: Lancet Date: 2011-02-19 Impact factor: 79.321
Authors: Joseph S Ross; Jersey Chen; Zhenqiu Lin; Héctor Bueno; Jeptha P Curtis; Patricia S Keenan; Sharon-Lise T Normand; Geoffrey Schreiner; John A Spertus; Maria T Vidán; Yongfei Wang; Yun Wang; Harlan M Krumholz Journal: Circ Heart Fail Date: 2009-11-10 Impact factor: 8.790
Authors: Larry A Allen; Karen E Smoyer Tomic; David M Smith; Kathleen L Wilson; Irene Agodoa Journal: Circ Heart Fail Date: 2012-10-16 Impact factor: 8.790
Authors: Cathy A Eastwood; Jonathan G Howlett; Kathryn M King-Shier; Finlay A McAlister; Justin A Ezekowitz; Hude Quan Journal: Can J Cardiol Date: 2014-02-28 Impact factor: 5.223
Authors: Marat Fudim; Christopher M O'Connor; Allison Dunning; Andrew P Ambrosy; Paul W Armstrong; Adrian Coles; Justin A Ezekowitz; Stephen J Greene; Marco Metra; Randall C Starling; Adriaan A Voors; Adrian F Hernandez; G Michael Felker; Robert J Mentz Journal: Eur J Heart Fail Date: 2017-10-29 Impact factor: 15.534
Authors: Alexander C Razavi; Dominique J Monlezun; Alexander Sapin; Leah Sarris; Emily Schlag; Amber Dyer; Timothy Harlan Journal: Am J Lifestyle Med Date: 2019-07-14
Authors: Devraj Sukul; Shashank S Sinha; Andrew M Ryan; Michael W Sjoding; Scott L Hummel; Brahmajee K Nallamothu Journal: Am J Med Date: 2017-06-10 Impact factor: 4.965
Authors: Cristina Pacho; Mar Domingo; Raquel Núñez; Josep Lupón; Julio Núñez; Jaume Barallat; Pedro Moliner; Marta de Antonio; Javier Santesmases; Germán Cediel; Santiago Roura; M Cruz Pastor; Jordi Tor; Antoni Bayes-Genis Journal: BMC Geriatr Date: 2018-05-09 Impact factor: 3.921